Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice that warned about potential delays in updates.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a site-wide funding/operational notice (including cc.nih.gov and opm.gov references) and updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded metadata fields such as Results First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted, a revision banner (v3.4.0), and a Show glossary toggle. These are UI/metadata updates and do not modify core study content.SummaryDifference0.4%

- Check42 days agoChange DetectedA minor version update from v3.3.3 to v3.3.4 was applied. No study details or user-facing content appear to be altered.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section now includes Florida; 'Florida Locations' has been removed and the page revision updated to v3.3.3, with the HHS Vulnerability Disclosure link removed.SummaryDifference0.2%

- Check91 days agoChange DetectedMinor site revision labels updated: added Revision: v3.3.2 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.